SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

07 Aug 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 3637.10 millions grew by 7.37 % from Rs. 3387.40 millions.Net Profit recorded in the quarter ended June 2026 rise to 45.29% to Rs. 961.50  millions  compared to R. 661.80 millions in corresponding previous quarter.Operating profit for the quarter ended June 2026 rose to 1034.80 millions as compared to 943.70 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3637.10 3387.40 7.37 3637.10 3387.40 7.37 14079.70 0.00 0.00
Other Income 38.80 40.30 -3.72 38.80 40.30 -3.72 173.40 0.00 0.00
PBIDT 1034.80 943.70 9.65 1034.80 943.70 9.65 4740.00 0.00 0.00
Interest 1.40 1.20 16.67 1.40 1.20 16.67 5.50 0.00 0.00
PBDT 1351.40 942.50 43.38 1351.40 942.50 43.38 4734.50 0.00 0.00
Depreciation 60.20 54.40 10.66 60.20 54.40 10.66 235.90 0.00 0.00
PBT 1291.20 888.10 45.39 1291.20 888.10 45.39 4498.60 0.00 0.00
TAX 329.70 226.30 45.69 329.70 226.30 45.69 1229.50 0.00 0.00
Deferred Tax 19.40 -3.10 -725.81 19.40 -3.10 -725.81 44.60 0.00 0.00
PAT 961.50 661.80 45.29 961.50 661.80 45.29 3269.10 0.00 0.00
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 0.00 0.00
PBIDTM(%) 28.45 27.86 2.13 28.45 27.86 2.13 33.67 0.00 0.00

Procter&Gamble Healt Share Price

6023.65 -64.25 (-1.06%)
07-Aug-2026 10:19 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1944.85
Dr. Reddys Labs. 1163.40
Cipla 1465.60
Lupin 2400.90
Zydus Lifesciences 1102.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: